A detailed history of Morningstar Investment Services LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Morningstar Investment Services LLC holds 12,844 shares of GILD stock, worth $1.17 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,844
Previous 13,794 6.89%
Holding current value
$1.17 Million
Previous $949,000 13.17%
% of portfolio
0.01%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$66.59 - $83.99 $63,260 - $79,790
-950 Reduced 6.89%
12,844 $1.07 Million
Q2 2024

Aug 13, 2024

BUY
$63.15 - $72.88 $129,583 - $149,549
2,052 Added 17.48%
13,794 $949,000
Q1 2024

May 15, 2024

SELL
$71.58 - $87.29 $246,879 - $301,063
-3,449 Reduced 22.7%
11,742 $857,000
Q4 2023

Feb 13, 2024

BUY
$73.27 - $83.09 $618,178 - $701,030
8,437 Added 124.92%
15,191 $1.23 Million
Q3 2023

Nov 14, 2023

BUY
$73.94 - $80.67 $69,059 - $75,345
934 Added 16.05%
6,754 $509,000
Q2 2023

Aug 14, 2023

BUY
$76.01 - $86.7 $106,490 - $121,466
1,401 Added 31.7%
5,820 $443,000
Q1 2023

May 15, 2023

BUY
$77.31 - $88.08 $341,632 - $389,225
4,419 New
4,419 $366,000
Q4 2022

Feb 10, 2023

BUY
$62.32 - $89.47 $35,210 - $50,550
565 Added 10.04%
6,191 $528,000
Q3 2022

Nov 14, 2022

BUY
$59.54 - $68.01 $334,972 - $382,624
5,626 New
5,626 $395,000
Q2 2022

Aug 12, 2022

SELL
$57.72 - $65.01 $2.99 Million - $3.37 Million
-51,875 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$57.92 - $72.58 $3 Million - $3.77 Million
51,875 New
51,875 $3.1 Million
Q3 2021

Nov 12, 2021

SELL
$67.69 - $73.03 $3.33 Million - $3.59 Million
-49,167 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$63.47 - $69.35 $3.86 Million - $4.22 Million
-60,818 Reduced 55.3%
49,167 $3.34 Million
Q1 2021

May 11, 2021

BUY
$60.0 - $68.46 $1.55 Million - $1.77 Million
25,868 Added 30.75%
109,985 $7.2 Million
Q4 2020

Feb 11, 2021

BUY
$56.65 - $64.55 $4.77 Million - $5.43 Million
84,117 New
84,117 $4.9 Million
Q2 2019

Aug 13, 2019

SELL
$61.87 - $69.38 $5.94 Million - $6.66 Million
-95,972 Closed
0 $0
Q1 2019

May 13, 2019

BUY
$62.53 - $70.05 $6 Million - $6.72 Million
95,972 New
95,972 $6.24 Million
Q4 2018

Feb 14, 2019

SELL
$60.54 - $79.0 $178,411 - $232,813
-2,947 Closed
0 $0
Q3 2018

Nov 08, 2018

SELL
$71.28 - $78.92 $397,243 - $439,821
-5,573 Reduced 65.41%
2,947 $228,000
Q2 2018

Aug 03, 2018

SELL
$64.88 - $75.68 $425,028 - $495,779
-6,551 Reduced 43.47%
8,520 $604,000
Q1 2018

May 10, 2018

SELL
$72.84 - $88.8 $658,182 - $802,396
-9,036 Reduced 37.48%
15,071 $1.14 Million
Q4 2017

Feb 08, 2018

SELL
$71.15 - $83.52 $223,482 - $262,336
-3,141 Reduced 11.53%
24,107 $1.73 Million
Q3 2017

Nov 09, 2017

BUY
$72.11 - $85.47 $1.96 Million - $2.33 Million
27,248
27,248 $2.21 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $114B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Morningstar Investment Services LLC Portfolio

Follow Morningstar Investment Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morningstar Investment Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Morningstar Investment Services LLC with notifications on news.